Association between platelet MAO activity and lifetime drug use in a longitudinal birth cohort study

dc.contributor.authorSakala, Katre
dc.contributor.authorKasearu, Kairi
dc.contributor.authorKatus, Urmeli
dc.contributor.authorVeidebaum, Toomas
dc.contributor.authorHarro, Jaanus
dc.date.accessioned2023-04-25T11:06:31Z
dc.date.available2023-04-25T11:06:31Z
dc.date.issued2022
dc.description.abstractRationale: Platelet monoamine oxidase (MAO) activity, a marker of central serotonergic capacity, has been associated with a variety of problem behaviours. However, studies on platelet MAO activity and addictive drugs has not been consistently linked with addiction or found to predict illicit substance use initiation or frequency. Objectives: Platelet MAO activity and illicit drug use was examined in a longitudinal birth cohort study. Methods: The sample included both birth cohorts (original n = 1238) of the Estonian Children Personality Behaviour and Health Study. Longitudinal association from age 15 to 25 years between platelet MAO activity and lifetime drug use was analyzed by mixed-effects regression models. Differences at ages 15, 18 and 25 were analyzed by t-test. Cox proportional hazard regression analysis was used to assess the association between platelet MAO activity and the age of drug use initiation. Results: Male subjects who reported at least one drug use event had lower platelet MAO activity compared to nonusers, both in cross-sectional and longitudinal analysis. Males with low platelet MAO activity had started to use drugs at a younger age. Moreover, in male subjects who had experimented with illicit drugs only once in lifetime, low platelet MAO activity was also associated with higher risk at a younger age. In females, platelet MAO activity was not associated with drug use. Conclusion: In males, low platelet MAO activity is associated with drug abuse primarily owing to risk taking at early age.et
dc.identifier.urihttps://doi.org/10.1007/s00213-021-06035-y
dc.identifier.urihttp://hdl.handle.net/10062/89699
dc.language.isoenget
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/728018///Eat2beNICEet
dc.relation.ispartofseriesPsychopharmacology (Berl). 2022 Jan;239(1):327-337.
dc.rightsinfo:eu-repo/semantics/openAccesset
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPlatelet monoamine oxidase (MAO) activityet
dc.subjectlifetime drug useet
dc.subjectlongitudinal birth cohort studyet
dc.subjectsurvival analysiset
dc.subjectgenderet
dc.titleAssociation between platelet MAO activity and lifetime drug use in a longitudinal birth cohort studyet
dc.typeinfo:eu-repo/semantics/articleet

Failid

Originaal pakett

Nüüd näidatakse 1 - 2 2
Laen...
Pisipilt
Nimi:
Sakala_et_al_Psychopharmacology.pdf
Suurus:
328.18 KB
Formaat:
Adobe Portable Document Format
Kirjeldus:
Laen...
Pisipilt
Nimi:
Sakala_Supplementary_file1.pdf
Suurus:
100.08 KB
Formaat:
Adobe Portable Document Format
Kirjeldus:
Supplementary table

Litsentsi pakett

Nüüd näidatakse 1 - 1 1
Pisipilt ei ole saadaval
Nimi:
license.txt
Suurus:
1.71 KB
Formaat:
Item-specific license agreed upon to submission
Kirjeldus: